Linagliptin 5

Linagliptin
LINALIGLIP  is an oral medication used in the treatment of type 2 diabetes mellitus. It belongs to a class of drugs called dipeptidyl peptidase-4 (DPP-4) inhibitors, which work by increasing the levels of certain hormones that stimulate insulin production and regulate blood sugar levels.
Here are some key points about LINALIGLIP:
Indications: LINALIGLIP is primarily used to improve glycemic control in adults with type 2 diabetes. It is often prescribed in combination with diet and exercise, as well as other antidiabetic medications, such as metformin or sulfonylureas.
Mechanism of action: LINALIGLIP works by inhibiting the enzyme DPP-4, which normally breaks down incretin hormones like glucagon-like peptide-1 (GLP-1). By inhibiting DPP-4, LINALIGLIP prolongs the action of GLP-1 and glucose-dependent insulinotropic peptide (GIP), increasing insulin secretion and decreasing glucagon release from the pancreas.
Efficacy: Clinical studies have shown that LINALIGLIP can effectively reduce blood glucose levels in patients with type 2 diabetes. It helps improve glycemic control and may also have additional benefits such as weight neutrality and a low risk of hypoglycemia (low blood sugar).
Dosage and administration: The usual recommended dose of LINALIGLIP is 5 mg taken orally once daily, with or without food. The dosage may need to be adjusted for patients with kidney impairment or those taking certain medications that interact with LINALIGLIP.
Side effects: Common side effects of LINALIGLIP may include upper respiratory tract infections, urinary tract infections, headache, and gastrointestinal symptoms like diarrhea or abdominal pain. Severe side effects are rare but can include severe allergic reactions or pancreatitis. It is important to discuss any side effects or concerns with a healthcare provider.
Precautions and contraindications: LINALIGLIP is generally well-tolerated, but it should be used with caution in patients with severe kidney impairment. It is not recommended for use in patients with type 1 diabetes or diabetic ketoacidosis. It may interact with certain medications, so it's important to inform your healthcare provider about all the medications you are taking.
For further information please contact:
info@sterispharma.com
order now:-  https://www.sterisonline.com/product/linaliglip-5-134269